Last reviewed · How we verify

Pernicious anemia — Treatment Landscape & Competitive Intelligence

Pernicious anemia (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Pernicious anemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Thiamine Hydrochloride THIAMINE Pfizer thiamine (vit B1) Heat shock protein HSP 90-alpha 1993-01-01
Cyanokit HYDROXOCOBALAMIN Btg Intl Antidote 1978-01-01
Cyanocobalamin Co 57 cyanocobalamin (57Co) Mallinckrodt Radioactive Diagnostic Agent Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial, Methionine synthase, Methionine synthase reductase 1968-01-01
Hydroxycobalamin Hydroxycobalamin Christian Medical College, Vellore, India
Thiamin Thiamin Hospital Sao Domingos Thiamin pyrophosphokinase 1, Thiamine transporter 1, Thiamine-triphosphatase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 4 drugs in Pernicious anemia
  2. Btg Intl · 1 drug in Pernicious anemia
  3. Christian Medical College, Vellore, India · 1 drug in Pernicious anemia
  4. Hospital Sao Domingos · 1 drug in Pernicious anemia
  5. Mallinckrodt · 1 drug in Pernicious anemia
  6. Pfizer · 1 drug in Pernicious anemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Pernicious anemia:

Cite this brief

Drug Landscape (2026). Pernicious anemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/pernicious-anemia. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing